Abstract
BACKGROUND: While the type and the number of treatments for Coronavirus Disease 2019 (COVID-19) have substantially evolved since the start of the pandemic a significant number of hospitalized patients continue to succumb. This requires ongoing research in the development and improvement of early risk stratification tools.
METHODS: We developed a prognostic score using epidemiological, clinical, laboratory, and treatment variables collected on admission in 130 adult COVID-19 patients followed until in-hospital death (N.=38) or discharge (N.=92). Potential variables were selected via multivariable logistic regression modelling conducted using a logistic regression univariate analysis to create a combined index.
RESULTS: Age, Charlson Comorbidity Index, P/F ratio, prothrombin time, C-reactive protein and troponin were the selected variables. AUROC indicated that the model had an excellent AUC value (0.971, 95% CI 0.926 to 0.993) with 100% sensitivity and 83% specificity for in-hospital mortality. The Hosmer-Lemeshow calibration test yielded non-significant P values (χ2=1.79, P=0.99) indicates good calibration.
CONCLUSIONS: This newly developed combined index could be useful to predict mortality of hospitalized COVID-19 patients on admission.
Original language | English |
---|---|
Pages (from-to) | 25-32 |
Number of pages | 8 |
Journal | Minerva Respiratory Medicine |
Volume | 62 |
Issue number | 1 |
DOIs | |
Publication status | Published - Mar 2023 |
Keywords
- COVID-19
- Hospital mortality
- Respiratory insufficiency
- SARS-CoV-2